Phase II trial of preoperative radiation therapy with capecitabine in rectal cancer (UMCC 0046)
Phase of Trial: Phase II
Latest Information Update: 15 Jan 2019
At a glance
- Drugs Capecitabine (Primary)
- Indications Adenocarcinoma; Rectal cancer
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 09 Jan 2008 Status changed from in progress to discontinued.
- 15 Oct 2005 New trial record.